A team of chemists and astronomers have made a discovery in the field of astrochemistry: the identification of cyanocoronene, ...

Human metabolism is a complex web of chemical processes and interactions between our cells and the microbes living within us.

Understanding how molecules interact is central to biology: from decoding how living organisms function to uncovering disease ...

For its investment, Roche will have the right to co-develop and co-commercialize petrelintide, an investigational amylin receptor agonist that helps lower blood sugar levels and slow down the emptying ...

AbbVie is joining the chase for new obesity drugs, but rather than getting a me-too GLP-1 drug, the pharmaceutical giant is landing rights to a clinical-stage molecule that goes after two novel ...

Novo Nordisk’s NVO amycretin, which targets GLP-1 and amylin in one molecule, generated 24% placebo-adjusted weight loss in a phase 1b/2a study in patients with obesity or overweight after 36 ...

“Our proven GPCR structure-based drug discovery platform enabled us to rapidly advance ACCG-2671 as the lead amylin receptor agonist. We are now developing a series of amylin-based drug candidates ...

Structure Therapeutics Inc. has announced the selection of its lead oral small molecule amylin receptor agonist, ACCG-2671, which shows promising preclinical results including potent target ...

“Our proven GPCR structure-based drug discovery platform enabled us to rapidly advance ACCG-2671 as the lead amylin receptor agonist. We are now developing a series of amylin-based drug ...